DENVER--(BUSINESS WIRE)--More than thirty of the industry’s leading investors and strategic partners will attend presentations by the region’s most innovative life science companies at the 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC), September 21-22 at the Brown Palace Hotel, Denver. The announcement is made by Holli Riebel (formerly Baumunk), President and CEO of the Colorado BioScience Association (CBSA) who says, “Leading biotech, device, diagnostic and pharma investors from across the country and world will be coming to Denver to create the newest deals and shape the future landscape of the life science industry.”
The conference will present a strong slate of Rocky Mountain region companies to the investors. Thirty-one companies were selected to present from over fifty applicants spanning a range of sectors within the industry.
“We’ve encouraged investors to come see all the Rocky Mountain region has to offer, as the largest and most advanced area between both coasts, garnering more than $11.5 billion dollars in financings and acquisitions since the end of 2007. Our bioscience companies are some of the most successful up and coming companies in the nation,” Riebel said. “RMLIPC 2011 is a great opportunity to visit Colorado and connect in real-time.”
Investors will listen to 15-minute presentations from each company highlighting their products and goals followed by a question and answer session with selected investor panelists. Investors will also have ample opportunity to network and meet individually with the companies. This conference offers both breadth and depth for investment and partnership opportunities.
The following investors and strategic partners will be attending RMLIPC 2011:
|
Apposite Capital, London, England |
||
|
BioVentures, Wellesley, MA |
||
|
Boston Equity Advisors, Canton, MA |
||
|
Boulder Ventures, Boulder, CO |
||
|
Bristol-Myers Squibb, New York, NY |
||
|
Canaan Partners, Menlo Park, CA |
||
|
Charter Life Sciences, Santa Clara, CA |
||
|
Covidien, Mansfield, MA |
||
|
CSU Ventures, Fort Collins, CO |
||
|
Delphi Ventures, Menlo Park, CA |
||
|
Doremus Advisory Services, New York, NY |
||
|
Draper Fisher Jurvetson, Menlo Park, CA |
||
|
Frontier Angels, Polson, MT |
||
|
High Country Venture, Boulder, CO |
||
|
Johnson & Johnson, New Brunswick, NJ |
||
|
Longitude Capital, Menlo Park, CA |
||
|
Lumira Capital, Palo Alto, CA |
||
|
MedImmune, Gaithersburg, MD |
||
|
Merck Ventures, Montvale, NJ |
||
|
Morgenthaler Ventures, Menlo Park, CA |
||
|
OK Life Sciences Fund, Tulsa, OK |
||
|
OnSet Ventures, Menlo Park, CA |
||
|
Red Script Ventures, Brunswick, NJ |
||
|
Research Corp BioVentures, Tucson, AZ |
||
|
Sanderling Ventures, San Mateo, CA |
||
|
Sevin Rosen Funds, Palo Alto, CA |
||
|
Sun Mountain Capital, Santa Fe, NM |
||
|
Takeda Ventures, Palo Alto, CA |
||
|
TPG Biotech, San Francisco, CA |
||
|
Volcano Capital, New York, NY |
||
|
vSpring Capital, Salt Lake City, UT |
||
About The Rocky Mountain Life Science Investor and Partnering Conference
The second Rocky Mountain Life Science Investor & Partnering Conference is building upon the success of the inaugural conference in 2009 to showcase 31 of the most innovative life science companies from the Rocky Mountain region. RMLIPC includes companies, investors and representatives from Arizona, Colorado, Montana, New Mexico, Oklahoma, Utah and Canada. The conference will open with a reception at the Colorado Governor’s Mansion September 21st and follow with a full day of company presentations and keynote speakers including Peter A. Gottlieb, MD, Professor of Pediatrics and Medicine Barbara Davis Center at the University of Colorado; Dennis R. Roop, Ph.D., Director of The Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology at the University of Colorado Anschutz Medical Campus; and Roy Davis, President of Johnson & Johnson Corporate Development. For more information and registration details, visit http://www.RockyMtnBioInvest.com.
About Colorado BioScience Association
The CBSA is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 350 members, CBSA actively works to promote the growth of the industry by working for a better business environment, grow the state's biotech workforce, fight for policies that support a strong bioscience industry in the state and speak with a single voice on behalf of the industry. For more information, visit http://www.cobioscience.com.